Sulfhydryl requirement for alpha adrenergic receptor activity and melanophore stimulating hormone (MSH) action on melanophores.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology; D002729:Chloromercuribenzoates / Q000494:pharmacology; D002856:Chromatophores / Q000187:drug effects*; D000242:Cyclic AMP / Q000494:pharmacology; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D008116:Lizards; D009074:Melanocyte-Stimulating Hormones / Q000037:antagonists & inhibitors*; D008628:Mercury / Q000494:pharmacology; D009941:Organomercury Compounds / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D013438:Sulfhydryl Compounds / Q000494:pharmacology*; D013451:Sulfonic Acids / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D002729:Chloromercuribenzoates; D009941:Organomercury Compounds; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013438:Sulfhydryl Compounds; D013451:Sulfonic Acids; D010643:Phenoxybenzamine; D003983:Dibenzylchlorethamine; D009074:Melanocyte-Stimulating Hormones; D013806:Theophylline; D000242:Cyclic AMP; D008628:Mercury; D005033:Ethylmaleimide; D010646:Phentolamine